PT-141 (Bremelanotide), single vial

Melanocortin receptor agonist

PT-141 (Bremelanotide)

Melanocortin receptor agonist. Supplied for laboratory research use only.

  • MC4 receptor agonist (bremelanotide); FDA-approved as Vyleesi
  • Approval narrow: HSDD in premenopausal women only, not men
  • Not approved by EMA, MHRA, or TGA
  • Supplied for laboratory research use only. Not for human or veterinary use.
$239.99$359.97 Save 33%
Every vial 10 mg
Choose your supply
Most Popular
Best Value
In stock, ready to ship

90-Day Money-Back Guarantee

Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.

Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.

What it is
CompoundPT-141 (Bremelanotide), also designated Bremelanotide
ClassMelanocortin receptor agonist
FormLyophilised powder, supplied in a vial
OriginatorPalatin Technologies
Development status

PT-141 is approved by the FDA as Vyleesi, on 21 June 2019, for hypoactive sexual desire disorder in premenopausal women only. It is not approved for men and is not a general libido drug. This product is not that medicine and is supplied for laboratory research use only.

Development status is stated above. No efficacy claim is made on this page.

Shipping & returns
ReturnsNinety days from delivery. Contact us and we will refund the purchase price.
PT-141 (Bremelanotide) $239.99

The specifics

The details, if you want them.

DeveloperPalatin Technologies
Also known asBremelanotide acetate, Vyleesi (FDA-approved brand name)
ClassMelanocortin receptor agonist (alpha-MSH analogue)
Amino acids7
FormAs an FDA-approved pharmaceutical, this molecule is a pre-filled auto-injector under its approved label; RUO research vials are a separate, unapproved product
Receptor target(s)Melanocortin 4 receptor (MC4R), primarily

Development

Where it is up to.

Peer-reviewed and the basis for FDA approval, for one narrow indication. Not approved by the EMA, MHRA, or TGA.

Questions

The questions people actually ask.

What is PT-141?
A synthetic 7-amino-acid peptide, also called bremelanotide, developed by Palatin Technologies. This product is a research-only vial, not a prescription medicine.
Is this the same as Vyleesi?
PT-141/bremelanotide is FDA-approved as Vyleesi, but only for hypoactive sexual desire disorder in premenopausal women — not approved for men. This vial is a separate, unbranded research product.
What does "Research Use Only" mean?
Research Use Only means exactly that: intended for laboratory and research settings only, not for human or animal use, consumption, diagnosis, treatment, cure, or prevention of any disease.
How is this vial supplied?
As a vial of lyophilised (freeze-dried) powder, sold for laboratory and research use only.
What is your refund policy?
Ninety days from delivery. If you decide against it inside that window, contact hello@getmrpeps.com and we will refund the purchase price. Damaged or incorrect orders are replaced or refunded regardless.